Product Categories
| Country: | United States |
|---|---|
| Tel: | |
| Mobile: | 6314854226 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| GYY-4137 Morpholine salt | C15H25N2O3PS2 | 106740-09-4 | Details |
| Paroxetine Mesylate | C20H24FNO6S | 217797-14-3 | Details |
| N-((4-(5-Methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)acetamide | C18H16N2O4S | 198471-06-6 | Details |
| Parecoxib Impurity 24 | C20H20N2O4S | 198470-82-5 | Details |
| Cefazolin EP Impurity G | C11H10N6O4S | 1172998-53-6 | Details |
| Posaconazole Diastereoisomer Related Compound 2 | C21H21F2N3O4S | 166583-12-6 | Details |
| Deoxyandrographolide | C20H30O4 | 79233-15-1 | Details |
| Heptakis(6-deoxy-6-thio)-beta-cyclodextrin | C42H70O28S7 | 160661-60-9 | Details |
| tert-butyl 4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazine-1-carboxylate | C19H27N5O4 | 1260939-66-9 | Details |
| Monodes(N-carboxymethyl)valine Daclatasvir | C33H39N7O3 | 1007884-60-7 | Details |
| 1-Methyl-4-sulfopyridinium Hydroxide Inner Salt | C6H7NO3S | 4416-69-7 | Details |
| 3-(4-Methylphenyl)-5-(trifluoromethyl)-1H-pyrazole | C11H9F3N2 | 219986-64-8 | Details |
| Palbociclib Impurity 025 | C25H29N7O3 | 2174002-16-3 | Details |
| 1-methylpyridin-1-ium-2-carboxamide chloride | 21032-31-5 | Details |
| (R)-Terazosin | C19H25N5O4 | 109351-34-0 | Details |
| DOTA-NOC | C69H92N14O18S2 | 619300-53-7 | Details |
| Rifamycin S | C37H45NO12 | 13553-79-2 | Details |
| 6,7-dimethoxy-2-piperazin-1-ylquinazolin-4-amine hydrochloride | C14H20ClN5O2 | 70843-11-7 | Details |
| Mogrol | C30H52O4 | 88930-15-8 | Details |
| Terazosin EP Impurity E | C24H28N8O4 | 102839-00-9 | Details |
| Celecoxib Related Compound B | C17H14F3N3O2S | 331943-04-5 | Details |
| Valdecoxib Impurity B | C32H25N3O6S2 | 1373038-60-8 | Details |
| Valdecoxib Impurity I | C16H15N3O5S2 | 1373038-59-5 | Details |
| Terbutaline Impurity 6 hydrobromide | C26H30BrNO3 | 28924-20-1 | Details |
| Triethylene Glycol Mono(2-propynyl) Ether | C9H16O4 | 208827-90-1 | Details |
| endo-BCN-PEG4-NHS ester | 1807501-86-5 | Details |
| Proteinase K | C29H27N2O12P | 39450-01-6 | Details |
| 3-(4-hydroxynaphthalen-1-yl)-1-phenylpropan-1-one | C19H16O2 | 126113-24-4 | Details |
| N-Tert-Butyldibenzylamine | C18H23N | 30923-82-1 | Details |
| Celecoxib Impurity A | C17H14F3N3O2S | 170570-01-1 | Details |
| Valdecoxib Impurity E | C16H11Cl2NO5S2 | 1373038-63-1 | Details |
| 2-Chloro Vonoprazan | C17H15ClFN3O2S | 928325-68-2 | Details |
| Terazosin Related Compound A | C19H25N5O4 | 60548-08-5 | Details |
| Nifuratel Impurity 2 | C10H11N3O6S | 1445990-09-9 | Details |
| Linezolid Impurity 42 | C3H8ClNO | 725676-93-7 | Details |
| 19-Hydroxy-10-deacetyl baccatin-III | C29H36O11 | 154083-99-5 | Details |
| (3R,5R)-Rosuvastatin Calcium | C22H30CaFN3O6S | 1422515-55-6 | Details |
| Mirabegron impurity 003 | C8H7FN2O3 | 1018983-85-1 | Details |
| Resiquimod-[d5] | C17H22N4O2 | 2252319-44-9 | Details |
| Olanzapine Impurity 25 | C6H6N2 | 52833-34-8 | Details |
| Linezolid Impurity 44 | C5H9NO2 | 183805-10-9 | Details |
| Hydroxy Ivabradine | C15H21NO4 | 1235547-07-5 | Details |
| Nifuratel Impurity 4 | C9H9N3O6 | 41359-15-3 | Details |
| 2-(benzyl(tert-butyl)amino)-1-(3,5-bis(benzyloxy)phenyl)ethan-1-one sulfate | C33H35NO3.H2O4S | 882066-15-1 | Details |
| Polyadenosinic acid potassium salt | C10H13KN5O7P | 26763-19-9 | Details |
| p-[N-(p-Fluorophenyl)formimidoyl]phenol | C13H10FNO | 3382-63-6 | Details |
| Febuxostat Impurity 23 | C15H13NO5S | 2073891-59-3 | Details |
| 1-(1-phenylethyl)imidazole | C11H12N2 | 60197-34-4 | Details |
| Palbociclib Impurity 10 | C41H55N11O5 | 2206135-30-8 | Details |
| Cy5-NHS ester | C37H43N3O10S2 | 146368-14-1 | Details |
| (2S)-Isopropyl 2-(((perfluorophenoxy)(phenoxy)phosphoryl)amino)propanoate | C18H17F5NO5P | 1256490-52-4 | Details |
| Palbociclib Impurity F | C14H22N4O2 | 1023594-49-1 | Details |
| Vonoprazan Impurity 24 | C17H14FN3O3S | 1883595-39-8 | Details |
| Dapoxetine Impurity 2 | C30H31NO2 | 2242008-37-1 | Details |
| Palbociclib Impurity 030 | C9H12N4O2 | 1211541-02-4 | Details |
| 6-Ethynyl-4,4-Dimethyl Thiochroman | C13H14S | 118292-06-1 | Details |
| Tetrabutylammonium periodate | C16H36INO4 | 65201-77-6 | Details |
| 15(S)-Latanoprost | C26H40O5 | 145773-22-4 | Details |
| Ingenol-5,20-acetonide | C23H32O5 | 77573-43-4 | Details |
| Atorvastatin EP Impurity C | C33H36CaF2N2O5 | 693793-53-2 | Details |
| (3S,5R)-Rosuvastatin | C22H28FN3O6S | 1242184-42-4 | Details |
| Rosuvastatin Impurity 12 | C25H32FN3O6S | 894787-93-0 | Details |
| Palbociclib Impurity 2 | C24H29N7O | 2204863-06-7 | Details |
| Dapoxetine Impurity 2 hydrochloride | C30H32ClNO2 | 2242008-38-2 | Details |
| Palbociclib Impurity 029 | C9H12N4O2 | 1566082-34-5 | Details |
| 1-Piperazinyl[(2R)-tetrahydro-2-furanyl]methanone | C9H16N2O2 | 412334-56-6 | Details |
| Mirabegron impurity 002 | C10H11NO2 | 81259-56-5 | Details |
| Leucosceptoside A | C30H38O15 | 83529-62-8 | Details |
| Lisinopril Impurity F | C21H37N3O5 | 1132650-67-9 | Details |
| PF-04457845 | C23H20F3N5O2 | 1020315-31-4 | Details |
| Chrysin-7-O-glucoronide | C21H18O10 | 35775-49-6 | Details |
| methyl 1-(2-chloroacetyl)-2-oxo-3H-indole-6-carboxylate | C12H10ClNO4 | 1160293-25-3 | Details |
| Palbociclib Impurity 022 | C14H20N4O4 | 1779124-68-3 | Details |
| 1-methylpyridin-1-ium-2-carboxamide iodide | 3861-69-6 | Details |
| Cefazolin Impurity D | C13H14N6O6S | 32510-61-5 | Details |
| Pendimethalin | C13H19N3O4 | 40487-42-1 | Details |
| Ethyl 2-bromothiophene-3-carboxylate | C7H7BrO2S | 632325-50-9 | Details |
| Dapoxetine Impurity 1 | C19H16O | 94305-25-6 | Details |
| MCP110 | C33H36N2O3 | 521310-51-0 | Details |
| Dabigatran Impurity 20 | C33H38N6O6 | 1408238-39-0 | Details |
| Terazosin EP Impurity O | C14H22N2O4 | 547730-06-3 | Details |
| Ethyl 5-bromothieno[3,2-b]thiophene-6-carboxylate | C9H7BrO2S2 | 2055722-78-4 | Details |
| 3-(4-(3-hydroxy-3-phenylpropoxy)naphthalen-1-yl)-1-phenylpropan-1-one | C28H26O3 | 2242008-36-0 | Details |
| Dacarbazine | C6H10N6O | 4342-03-4 | Details |
| Semax | C37H51N9O10S | 80714-61-0 | Details |
| Esmolol Impurity 1 | C13H16O4 | 81147-94-6 | Details |
| Dapagliflozin Impurity 3 | C21H25BrO6 | 1807632-95-6 | Details |
| Nα,Nα-Bis-Fmoc-L-cystine bis(tert-butyl ester) | C44H48N2O8S2 | 139592-37-3 | Details |
| Parecoxib Impurity 1 | C22H23N3O7S2 | 1708094-99-8 | Details |
| tert-butyl 4-(6-((8-cyclopentyl-5-methyl-7-oxo-6-vinyl-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate | C29H37N7O3 | 1941177-45-2 | Details |
| Olmesartan Impurity 13 | C14H11BrN4 | 138402-33-2 | Details |
| Terbutaline Impurity 22 | C22H20O4 | 1226543-90-3 | Details |
| Dapoxetine Impurity 8 | C30H31NO | 2245197-07-1 | Details |
| Dapoxetine Impurity 24 | C19H18O2 | 908291-72-5 | Details |
| Pantoprazole EP Impurity E | C32H28F4N6O8S2 | 2115779-15-0 | Details |
| N'-(5-Chloropyridin-2-yl)-N-[(1R,2R,4R)-4-(dimethylcarbamoyl)-2-[(5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridine-2-carbonyl)amino]cyclohexyl]oxamide | C24H30ClN7O4S | 1255529-24-8 | Details |
| Etomidate Impurity 1 | C11H12N2 | 844658-92-0 | Details |
| Fomesafen | C15H10ClF3N2O6S | 72178-02-0 | Details |
| Sodium 2-((2S,5S)-5-benzyl-3,6-dioxopiperazin-2-yl)acetate | C13H15N2NaO4 | 136983-81-8 | Details |
| Nifuratel Impurity 6 | C5H10N2O2S | 25517-72-0 | Details |
| Product Total： Product Page： | ||||
| 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 | ||||